NAMS NewAmsterdam Pharma Company N.V
$29.33▼ -3.46%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$3.43B
P/E Ratio
–
Div Yield
–%
52W Range
17.63 - 42.21
% vs 50 MA
-8.83%
% vs 200 MA
-8.18%
RSI-14
38.0
MACD Histogram
-0.6000
Beta (1Y vs SPY)
1.44
Free Cash Flow
-$30.64M
Gross Rev
$3.04M
Gross Profit
$3.04M
EBITDA
-$62.69M
COGS
–
Operating Exp
$61.46M
Operating Income
-$58.42M
EBIT
-$58.42M
Pretax Income
-$48.44M
Net Income
-$48.44M
EPS (Diluted)
-0.40
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Mar 2026 (Quarterly)
Social Sentiment
Avg +0.40 · 2 posts
NewsDiscussion🧬 5 Biotech Catalysts I’m Watching This Month — May 18–30
r/StockMarket · May 17, 2025
Discussion of an underrated name with a high probability of success.
positive
+0.60
NewsDiscussionFDA to phase out animal testing in drug development
r/wallstreetbets · Apr 10, 2025
The post’s discussion of NAMs data suggests a potential negative impact on companies relying on this methodology, however, this is only implied.
negative
+0.20
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.